Abstract
The meeting of the American Society of Microbiology was recently held in San Francisco, CA, USA – a gathering of experts in the fields of infectious diseases, microbiology and the pharmaceutical industry, among others. Owing to this large attendance and extensive coverage of many infectious disease topics, we focus on the optimization of anti-infective use in the clinical setting. We will cover antimicrobial stewardship, drugs with Gram-positive activity, and antifungal and antiretroviral agents.
Financial & competing interests disclosure
Rosa F Yeh has ongoing research support from Abbott Laboratories. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.